Zealand Pharma Logo

Zealand Pharma

Developing innovative peptide medicines for metabolic and inflammatory diseases.

ZEAL | CO

Overview

Corporate Details

ISIN(s):
DK0060257814 (+2 more)
LEI:
549300ITBB1ULBL4CZ12
Country:
Denmark
Address:
Sydmarken 11, 2860 Søborg
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Zealand Pharma is a biotechnology company specializing in the discovery, design, and development of innovative peptide-based medicines. With over 25 years of expertise in peptide engineering, the company focuses on creating next-generation therapeutics for metabolic and inflammatory diseases. Its clinical pipeline targets conditions with significant unmet medical needs, including obesity, congenital hyperinsulinism, short bowel syndrome, and chronic autoimmune diseases. Key programs involve novel peptide analogs such as amylin, long-acting GLP-2, and dual agonists for GLP-1/GLP-2 and glucagon/GLP-1 receptors. The company advances its portfolio through both proprietary development and strategic partnerships with major pharmaceutical firms.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-17 17:05
Major Shareholding Notification
English 5.6 KB
2025-10-17 17:05
Major Shareholding Notification
English 553.9 KB
2025-10-17 17:05
Major Shareholding Notification
English 377.4 KB
2025-09-30 17:05
Declaration of Voting Results & Voting Rights Announcements
English 5.6 KB
2025-09-11 22:00
Share Issue/Capital Change
English 5.9 KB
2025-08-20 22:00
Major Shareholding Notification
English 5.6 KB
2025-08-20 22:00
Major Shareholding Notification
English 550.7 KB
2025-08-20 22:00
Major Shareholding Notification
English 367.5 KB
2025-08-14 07:00
Earnings Release
English 25.7 KB
2025-08-14 07:00
Earnings Release
English 891.1 KB
2025-07-18 18:30
Major Shareholding Notification
English 301.0 KB
2025-07-18 18:30
Major Shareholding Notification
English 5.6 KB
2025-07-18 18:30
Major Shareholding Notification
English 516.4 KB
2025-06-30 17:05
Declaration of Voting Results & Voting Rights Announcements
English 5.6 KB
2025-06-18 17:29
Regulatory News Service
English 14.1 KB

Automate Your Workflow. Get a real-time feed of all Zealand Pharma filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Zealand Pharma

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Zealand Pharma via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Corline Biomedical AB Logo
Develops heparin-based coatings for medical device biocompatibility and regenerative medicine.
Sweden CLBIO
Cosma Spolka Akcyjna Logo
Produces natural hemp supplements and pharmaceutical raw materials for retail & wholesale markets.
Poland COS
COSMO Pharmaceuticals N.V. Logo
Specialty pharma for gastroenterology/dermatology, offering colon treatments & manufacturing services.
Netherlands COPN
Crossject Logo
Develops needle-free auto-injectors for rapid drug delivery in medical emergencies.
France ALCJ
CTC BIO, INC. Logo
Develops pharmaceuticals and feed additives for human and animal health using fermentation tech.
South Korea 060590
Cuorips Inc. Logo
Develops iPS cell therapies, like a cardiomyocyte sheet for severe heart failure.
Japan 4894
curacle co., ltd. Logo
Developing drugs for intractable diseases like diabetes caused by vascular damage and aging.
South Korea 365270
Curevac Logo
Pioneering mRNA technology to create vaccines and therapies for infectious diseases, cancer, and more.
Germany CVAC
Curocell Inc. Logo
Biotech developing enhanced CAR-T therapies for cancer using its OVIS™ platform.
South Korea 372320
Cyfuse Biomedical K.K. Logo Japan 4892

Talk to a Data Expert

Have a question? We'll get back to you promptly.